These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31439883)

  • 1. BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation.
    Khan N; Lakpa KL; Halcrow PW; Afghah Z; Miller NM; Geiger JD; Chen X
    Sci Rep; 2019 Aug; 9(1):12285. PubMed ID: 31439883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes.
    Khan N; Halcrow PW; Afghah Z; Baral A; Geiger JD; Chen X
    FASEB J; 2022 Mar; 36(3):e22184. PubMed ID: 35113458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-pore channels regulate Tat endolysosome escape and Tat-mediated HIV-1 LTR transactivation.
    Khan N; Halcrow PW; Lakpa KL; Afghah Z; Miller NM; Dowdy SF; Geiger JD; Chen X
    FASEB J; 2020 Mar; 34(3):4147-4162. PubMed ID: 31950548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression.
    Khan N; Halcrow PW; Lakpa LK; Rehan M; Chen X; Geiger JD
    J Neurovirol; 2021 Oct; 27(5):755-773. PubMed ID: 34550543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation.
    Khan N; Datta G; Geiger JD; Chen X
    J Neuroinflammation; 2018 Mar; 15(1):91. PubMed ID: 29558961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.
    Wang M; Yang W; Chen Y; Wang J; Tan J; Qiao W
    Retrovirology; 2018 Sep; 15(1):65. PubMed ID: 30241541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
    Chande AG; Baba M; Mukhopadhyaya R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
    Jiang MC; Lin JK; Chen SS
    Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
    Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
    J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter.
    Kim HY; Choi BS; Kim SS; Roh TY; Park J; Yoon CH
    Retrovirology; 2014 Aug; 11():67. PubMed ID: 25116364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
    Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
    Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidifying Endolysosomes Prevented Low-Density Lipoprotein-Induced Amyloidogenesis.
    Hui L; Soliman ML; Geiger NH; Miller NM; Afghah Z; Lakpa KL; Chen X; Geiger JD
    J Alzheimers Dis; 2019; 67(1):393-410. PubMed ID: 30594929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus.
    Li CJ; Wang C; Pardee AB
    J Biol Chem; 1994 Mar; 269(10):7051-4. PubMed ID: 8125909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
    Zhang HS; Ruan Z; Sang WW
    J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the Uptake and Transactivation Function of HIV-1 Tat Protein in a Trans-cellular Cocultivation Setup.
    Ruiz AP; Prasad VR
    Methods Mol Biol; 2016; 1354():353-66. PubMed ID: 26714724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.